Page last updated: 2024-10-26

dihydrocytochalasin b and Adenocarcinoma

dihydrocytochalasin b has been researched along with Adenocarcinoma in 1 studies

dihydrocytochalasin B: inhibits cell motility in many eucaryotic cells

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
"Although tolerance to tetraploidization, an intermediate state that further exacerbates CIN, is frequently mediated by TP53 dysfunction, we find that some genome-doubled tumours retain wild-type TP53."1.46Cyclin D mediates tolerance of genome-doubling in cancers with functional p53. ( Begum, J; Cerveira, J; Crockford, A; Cuomo, ME; Dewhurst, SM; Encheva, V; Grönroos, E; McGranahan, N; Patel, H; Purewal, S; Renshaw, MJ; Snijders, AP; Swanton, C; Zalmas, LP, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crockford, A1
Zalmas, LP1
Grönroos, E1
Dewhurst, SM1
McGranahan, N1
Cuomo, ME1
Encheva, V1
Snijders, AP1
Begum, J1
Purewal, S1
Cerveira, J1
Patel, H1
Renshaw, MJ1
Swanton, C1

Other Studies

1 other study available for dihydrocytochalasin b and Adenocarcinoma

ArticleYear
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 01-01, Volume: 28, Issue:1

    Topics: Adenocarcinoma; Aminopyridines; Benzimidazoles; Cell Line, Tumor; Colorectal Neoplasms; Cyclin C; Cy

2017